EQT to buy Dechra Pharmaceuticals for £4.5B

Swedish investment company EQT announced on Friday that it is acquiring Dechra Pharmaceuticals plc for £4.5 billion. Shareholders will receive £38.7 per Dechra share in the transaction, wh…